Baxter International (BAX) 10-Q2006 Q1 Quarterly report

Filed: 3 May 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: Abbott, Add, albumin, answered, antitrypsin, APB, ARALAST, ARC, arrived, asserting, assumption, Austrian, authorization, authorized, bear, behavior, Belgium, biopharmaceutical, Bloomington, Boston, Bulletin, chronic, commence, computation, contemplation, convenience, converting, costly, counterpart, cumulative, curve, customer, cycle, declaration, deliver, depreciation, dividend, dominant, eleven, embedded, emphysema, England, equal, exceeded, expansion, experience, exposed, flow, grantee, greater, hereditary, High, highly, hybrid, immaterial, Indiana, inhibitor, injectable, Intersegment, invalidate, irreversible, life, London, Los, manual, Meridian, modified, modify, nonvested, open, outlined, overnight, packaging, parallel, pipeline, preliminary, proportion, protection, publicly, published, quoted, ratably, recognition, reconciled, reconstituted, reconstitution, recover, regeneration, reorganized, repayable, retained, revocation, revoke, RSU, ruled, SAB, safely, satisfactory, scale, selecting, sevoflurane, sleep, solution, stage, streamlined, stronger, subscription, TheMedication, thereon, tissue, Tokyo, unaffiliated, understand, unpredictability, upgrade, version, vest, vested, vesting, week, weighting

Removed: acceleration, accumulated, actuarial, actuarially, adjustment, Alabama, alleging, andRenal, anesthesia, application, approval, approved, Arizona, arrangement, assessing, assuming, back, base, BBB, building, calculated, calculation, close, closed, collateral, combination, commercialization, competitively, concurrent, contingent, count, coupled, covenant, creation, differential, discount, distribute, divest, divided, downgrade, drawn, earlier, effectively, efficiency, enacted, enhance, entirety, equivalent, establishment, Europe, event, exclusive, executed, execution, expect, external, favorably, field, filing, final, floating, gain, hemoglobin, ii, iii, impairment, implemented, incentive, indefinite, individually, integrated, involve, Japan, law, limited, local, meet, Midwest, mirrored, Modernization, Montana, moved, negatively, Nevada, obligation, operationsDiscontinued, opposed, outlook, pain, paper, post, posted, prescription, processing, production, profitability, proprietary, protein, rating, reclassification, reevaluated, Regional, regulation, reissued, removed, repatriate, replenishment, represent, requested, retiree, Revenue, rolling, sealant, seasonality, secondary, securitize, served, settle, Shared, Similarly, SIP, solitary, spend, storage, strategy, subsidy, testing, Therapeutic, tool, trust, uncertainty, undertook, vary, virtue, voluntarily, voluntary, Wisconsin, worldwide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

BAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

Robert L. Parkinson, Jr., as Chairman of the Board and Chief Executive Officer of Baxter International Inc. (the “Company”), certifies, pursuant to 18 U.S.C §1350, as adopted pursuant to §906 of the Sarbanes–Oxley Act of 2002, that:

	(1)		the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2006 as filed with Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

	(2)		the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Robert L. Parkinson, Jr.

Robert L. Parkinson, Jr.
Chairman of the Board and Chief Executive Officer
May 3, 2006